BC-3402

N/A

Report date: 2024/04/19 17:23:10

Base Information

Drug NameBC-3402
Drug Alias NameBC-3402BC3402
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-Hepatitis A virus cellular receptor 2
TargetsHepatitis A virus cellular receptor 2
Therapy Area/IndicationsSolid tumoursMyelodysplastic SyndromesHematologic Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesWuxi BioCity
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesWuxi BioCity
Inactive CompaniesN/A
Active IndicationsSolid tumoursMyelodysplastic SyndromesHematologic Diseases +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A